Literature DB >> 35121861

Novel oxytocin spray is beneficial in ASD.

Sarah Lemprière1.   

Abstract

Entities:  

Year:  2022        PMID： 35121861     DOI： 10.1038/s41582-022-00627-8

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.

Authors:  Hidenori Yamasue; Masaki Kojima; Hitoshi Kuwabara; Miho Kuroda; Kaori Matsumoto; Chieko Kanai; Naoko Inada; Keiho Owada; Keiko Ochi; Nobutaka Ono; Seico Benner; Tomoyasu Wakuda; Yosuke Kameno; Jun Inoue; Taeko Harada; Kenji Tsuchiya; Kazuo Umemura; Aya Yamauchi; Nanayo Ogawa; Itaru Kushima; Norio Ozaki; Satoshi Suyama; Takuya Saito; Yukari Uemura; Junko Hamada; Yukiko Kano; Nami Honda; Saya Kikuchi; Moe Seto; Hiroaki Tomita; Noriko Miyoshi; Megumi Matsumoto; Yuko Kawaguchi; Koji Kanai; Manabu Ikeda; Itta Nakamura; Shuichi Isomura; Yoji Hirano; Toshiaki Onitsuka; Hirotaka Kosaka; Takashi Okada
Journal:  Brain       Date:  2022-04-18       Impact factor: 13.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.